In contrast with our findings from mouse PDAC tumor model, loss of SMAD4 in human pancreatic cancer patients was frequently identified and was associated with poor survival.[34] Such discrepancy may be due to the multiple functions of SMAD4 in pancreatic cancer development, differentiation, immune regulation at different cancer stages. Here, SMAD4 is linked to pancreatic neoplasm.